Kroiss, Matthias <br/><br/>
Drug Synergism of Proteasome Inhibitors and Mitotane by Complementary Activation of ER Stress in Adrenocortical Carcinoma Cells.  [electronic resource] 

 -  Hormones & cancer  12 2016 
 - 345-355 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1868-8500 
<br/><br/><label>Standard No.: </label>10.1007/s12672-016-0273-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adrenal Cortex Neoplasms--drug therapy<br/>Adrenocortical Carcinoma--drug therapy<br/>Antineoplastic Agents, Hormonal--pharmacology<br/>Bortezomib--pharmacology<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Drug Synergism<br/>Drug Therapy, Combination<br/>Endoplasmic Reticulum Stress--drug effects<br/>Endoribonucleases--genetics<br/>Eukaryotic Initiation Factor-2--metabolism<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>Leupeptins--pharmacology<br/>Mitotane--pharmacology<br/>Oligopeptides--pharmacology<br/>Phosphorylation<br/>Proteasome Inhibitors--pharmacology<br/>Protein Serine-Threonine Kinases--genetics<br/>X-Box Binding Protein 1--genetics